Cytopia adds and subtracts
Thursday, 10 July, 2008
Cytopia [ASX: CYT] has appointed Anadys Pharmaceuticals founder Dr Devron Averett as the company's new scientific advisor.
Averett has a Ph.D in microbiology and immunology and is an inventor of 17 current and nine pending US patents. He has had previous roles with Glaxo Wellcome and Burroughs Wellcome.
His work contributed to the discovery of a number of oncology and anti-viral drug candidates, including Zeffix, Emtriva and Ziagen.
The Melbourne-headquartered company has closed its New York office, losing business and corporate development VP Dr Shreefal Mehta, and will concentrate its US operations on California.
It has also appointed financial specialist Richard Haiduck as chief business advisor.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
